Our Team

Lmito's research team consists of experts in drug discovery in mitochondrial and cell metabolism, and the company will adopt a fully integrated pharmaceutical network (FIPNet) as our strategic business model.

Wheeseong Lee

Founder, CEO

Wheeseong has 25 years of experience in drug development related to oncology and inflammation, and his research is focused on the mitochondria and cell metabolism as related to immunology, neuroimmunology, and immuno-oncology.

He received his Ph.D from the University of Illinois at Urbana-Champaign, majoring in organic chemistry, and performed postdoctoral research at the California Institute of Technology.

Eunju Lee

COO

Eunju Lee is the Chief Operating Officer at Lmito Therapeutics and brings over 20 years of experience in Clinical Development and Corporate Strategy in both large and small pharmaceutical companies.

Eunju received an RN from Catholic University and an MBA from Sogang University.